Literature DB >> 9884065

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.

T Croci1, L Manara, G Aureggi, F Guagnini, M Rinaldi-Carmona, J P Maffrand, G Le Fur, S Mukenge, G Ferla.   

Abstract

We investigated the effect of the cannabinoid agonist (+)WIN-55212-2 on human ileum longitudinal smooth muscle preparations, either electrically stimulated or contracted by carbachol. Electrical field stimulation mostly activated cholinergic neurons, since atropine and tetrodotoxin (TTX), alone or coincubated, reduced twitch responses to a similar degree (85%). (+)WIN-55212-2 concentration-dependently inhibited twitch responses (IC50 73 nM), but had no additive effect with atropine or TTX. The cannabinoid CB1 receptor antagonist SR 141716 (pA2 8.2), but not the CB2 receptor antagonist, SR 144528, competitively antagonized twitch inhibition by (+)WIN-55212-2. Atropine but not (+)WIN-55212-2 or TTX prevented carbachol-induced tonic contraction. These results provide functional evidence of the existence of prejunctional cannabinoid CB1-receptors in the human ileum longitudinal smooth muscle. Agonist activation of these receptors prevents responses to electrical field stimulation, presumably by inhibiting acetylcholine release. SR 141716 is a potent and competitive antagonist of cannabinoid CB1 receptors naturally expressed in the human gut.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884065      PMCID: PMC1565718          DOI: 10.1038/sj.bjp.0702190

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.

Authors:  A A Izzo; N Mascolo; M Tonini; F Capasso
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 2.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 3.  Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.

Authors:  Peng Yang; Lirong Wang; Xiang-Qun Xie
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Authors:  Fabio Guagnini; Paola Cogliati; Sylvain Mukenge; Gianfranco Ferla; Tiziano Croci
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

5.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

6.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

7.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

Review 8.  Role of cannabinoids in chronic liver diseases.

Authors:  Anna Parfieniuk; Robert Flisiak
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

9.  Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.

Authors:  Gabriella Coruzzi; Maristella Adami; Elena Guaita; Alessandro Menozzi; Simone Bertini; Elena Giovannini; Giulio Soldani
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 10.  Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists.

Authors:  Helen Butler; Márta Korbonits
Journal:  Eur J Endocrinol       Date:  2009-09-03       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.